scorecardresearch
Add as a preferred source on Google
Monday, February 2, 2026
TopicIDMA

Topic: IDMA

Prices of some medicines could go up as cost of Chinese bulk drugs import surges

Drug makers have reached out to Modi govt with a proposal to bring a law under which price hikes could be made possible due to unforeseen factors.

China’s pollution is a headache for India – could cause a shortage of meds like Crocin

In 6 months, price of Chinese APIs have risen by 25-30%, with Indian firms saying it has made the production of common drugs unviable.

On Camera

India-EU FTA gives template for shared governance. It will rewire a market worth €27 trillion

The most obvious impact will be trade liberalisation, but the architecture of the agreement goes far beyond tariffs.

India spooks investors instead of calming them

Union Budget brings home to markets the unpleasant reality of fiscal dominance where RBI ends up prioritising deficit financing over its primary function of inflation control.

10X Budget beef-up for Intelligence Bureau capex, after Pahalgam & Red Fort terror attacks

After lapses exposed by terror attacks at Pahalgam and Delhi's Red Fort, Centre has hiked Intelligence Bureau's expenditure for investments in long-term assets from Rs 257 cr to Rs 2,549 cr. 

Swiss report should now close Op Sindoor debate. Knowing when to stop the fight is key too

The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.